Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria
© Alves et al.; licensee BioMed Central Ltd. 2013
Received: 4 July 2013
Accepted: 29 August 2013
Published: 31 August 2013
Severe malaria may be complicated by the acute respiratory distress syndrome (ARDS), which is associated with a high mortality. In the present report, a series of three cases of imported malaria complicated by refractory severe ARDS supported with extracorporeal membrane oxygenation (ECMO) is presented.
One female and two male adult patients (ages 39 to 53) were included. Two patients had Plasmodium falciparum infection and one patient had Plasmodium vivax and Plasmodium ovale co-infection. Anti-malarial therapy consisted in intravenous quinine (in two patients) and intravenous quinidine (in one patient), plus clindamycin or doxycycline.
Despite lung protective ventilation, a conservative strategy of fluid management, corticosteroids (two patients), prone position (two patients) and inhaled nitric oxide (one patient), refractory severe ARDS supervened (PaO2 to FiO2 ratio 68) and venovenous ECMO was then initiated. In one patient, a bicaval dual-lumen cannula was inserted; in the two other patients, a two-site configuration was used. Two patients survived to hospital-discharge (duration of ECMO support: 8.5 days) and one patient died from nosocomial sepsis and multi-organ failure after 40 days of ECMO support.
ECMO support allowed adequate oxygenation and correction of hypercapnia under lung protective ventilation, therefore reducing ventilator-induced lung injury. ECMO referral should be considered early in malaria complicated by severe ARDS refractory to conventional treatment.
KeywordsExtracorporeal membrane oxygenation Acute respiratory distress syndrome Malaria Plasmodium falciparum
Malaria is responsible for more than one million deaths annually, the majority of which occur in sub-Saharan Africa, with Plasmodium falciparum as the predominant organism . In non-endemic regions, most cases occur in non-immune or semi-immune travellers returning from endemic countries who do not adhere to malaria chemoprophylaxis [2, 3]. Such cases may be particularly severe, with in-hospital mortality rates reported as 11 to 40% [2, 4–6]. Acute respiratory distress syndrome (ARDS), which may develop in either the acute or late phases of infection, has been reported in 5 to 25% of adults with severe P. falciparum and in 1 to 10% of patients with severe Plasmodium vivax, with an attributable mortality of 20% in developed countries .
Extracorporeal membrane oxygenation (ECMO), referring to an extracorporeal circuit that directly oxygenates and removes carbon dioxide from the blood, may be considered in patients with ARDS whose pulmonary injury is so severe that positive-pressure ventilation alone is insufficient to maintain adequate gas exchange, or when adherence to lung-protective ventilation strategies results in unacceptable levels of hypercapnia and acidaemia . In most cases of ECMO for severe ARDS, venovenous ECMO is utilized, in which blood is withdrawn from and returned to a central vein. Recently, there has been increasing interest in ECMO as a result of advances in extracorporeal technology, with more efficient oxygenators and lower rates of complications, along with several reports of improved survival with ECMO for severe ARDS [8–11]. However, reports of ECMO for severe ARDS in patients with malaria are uncommon, with only two cases reported separately in the literature [5, 12], as well as one case of extracorporeal carbon dioxide elimination . In the present report, a series of three cases of malaria complicated by severe ARDS refractory to conventional treatment and supported with ECMO is presented.
Characteristics of patients with malaria-related severe ARDS requiring ECMO
Country of origin
P. vivax and P. ovale
Clinical deterioration (days)
Symptoms to hospital admission
Hospital to ICU admission
ICU admission to ECMO
IMV to ECMO
Renal replacement therapy
Renal replacement therapy
APACHE II *
Mechanical ventilation (days)
ICU LOS (days)
Respiratory and haematologic parameters before, during, and after ECMO
pH / PaCO2 (mmHg)
7.50 / 36.2
7.41 / 39.4
PC-peak / VC-plat (cmH2O)
Tidal volume (ml)
PaO2 / FiO2 (mmHg)
pH / PaCO2 (mmHg)
7.36 / 72.9
7.35 / 73.1
7.41 / 39.0
Fluid balance (L/24h)
Day 2 on ECMO
PC-peak / VC-plat (cmH2O)
Tidal volume (ml)
pH / PaCO2 (mmHg)
7.40 / 47.0
7.44 / 54.0
7.45 / 36.0
Fluid balance (L/24h)
End of ECMO
PC-peak / VC-plat (cmH2O)
Tidal volume (ml)
pH / PaCO2 (mmHg)
7.22 / 33.0
7.43 / 38.5
Fluid balance (L/24h)
pH / PaCO2 (mmHg)
7.47 / 30.7
7.44 / 38.0
A 46-year-old American woman presented with two weeks of cyclic fevers, night sweats, and myalgias (Table 1). She had recently returned from Uganda, where she worked in a rural area and was adherent to atovaquone and proguanil malaria prophylaxis. She was treated empirically for chloroquine-resistant P. falciparum with oral quinine and doxycycline, however she did not tolerate oral therapy due to nausea and vomiting, and required admission to a local hospital for initiation of intravenous quinidine and clindamycin. Her vital signs, physical exam, and chest X-ray were unremarkable. Initial blood smears showed 0.5% parasitaemia. Once PCR testing confirmed P. vivax and P. ovale and excluded P. falciparum, her treatment was changed to chloroquine; however severe hypoxemic respiratory failure with bilateral infiltrates developed by hospital day 4, requiring IMV, at which point intravenous therapy was resumed. PaO2 was 68 mmHg despite an FIO2 of 1.0, PEEP of 15 cm of water, a conservative strategy of fluid management and inhaled nitric oxide (iNO) (Table 2). Echocardiogram demonstrated normal cardiac function. She was transferred to the Columbia University College of Physicians and Surgeons (New York, NY, USA), where she was placed on ECMO with a 27Fr bicaval dual-lumen cannula via the right internal jugular vein under fluoroscopic and echocardiographic guidance [14, 15]. Cultures and blood smears in the ICU were negative for organisms. Anti-malarial therapy with intravenous quinidine and doxycycline was continued and she was successfully decannulated on ECMO day 10, and liberated from IMV seven days later. No arrhythmias occurred during quinine treatment. One month post-discharge, she was functioning independently. Two ECMO-related complications occurred: i) migration of the distal end of the cannula into a hepatic vein, identified by transesophageal echocardiogram on ECMO day 2 in the setting of a decrease in blood flow rates, followed by successful repositioning at the bedside; and ii) bleeding from the cannulation site and epistaxis that required a total of 8 units of packed red blood cells in the setting of low-level anticoagulation to maintain ECMO circuit integrity (mean activated partial thromboplastin time 46.5 seconds).
Informed consent was obtained from the patients for publication of this case series and any accompanying images after explanation of the report objectives.
In this report, three cases of imported malaria complicated by severe ARDS supported with ECMO are presented. Severe ARDS may be a complication of P. falciparum, P. vivax or P. ovale infections. In accordance with the WHO guidelines the presence of ARDS is a defining criterion for severe malaria . In all three cases, oxygenation and CO2 clearance through the membrane ECMO lung allowed the compliance to protective ventilation of the native lung with low tidal volumes (<6 ml/kg IBW) and low-fractional oxygen concentrations, limiting ventilator-induced lung injury . However, permissive hypercapnia is frequently necessary to allow low tidal volume protective ventilation in severe ARDS. This could be potentially harmful in patients with severe malaria, given that cerebral oedema with elevated intracranial pressures can complicate cerebral malaria  and that hypercapnia causes cerebral vasodilatation and intracranial pressure elevation. Moreover, microvascular congestion and sequestration of parasitized red blood cells was shown to be a common feature in cerebral malaria, leading to impaired tissue perfusion that may cause diffuse cerebral ischemia and increased intracranial blood volume . The use of ECMO in patients with severe malaria, allowing strict control of patient’s PaCO2, potentially limits intracranial pressure elevation.
Fluid management is crucial in patients with severe malaria. Taking into account that in these patients pulmonary edema secondary to increased pulmonary vascular permeability has been shown to be frequent, unpredictable and exacerbated by fluid loading, a conservative strategy of fluid management was followed in all three patients before and after ECMO initiation . Moreover, a liberal strategy of fluid management in acute lung injury has been previously associated with prolonged duration of mechanical ventilation and intensive care .
ECMO is not without risks and there are no definitive criteria for ECMO treatment in adult ARDS. Therefore, ECMO should only be considered in adult patients with malaria and severe ARDS refractory to conventional treatment. The recently conducted CESAR trial showed favourable results of ECMO referral for adult patients with severe ARDS . In that context, the same inclusion (Murray score >3.0 or pH <7.20) and exclusion (high pressure (>30 cm H2O of peak inspiratory pressure) or high FiO2 (>0.8) ventilation for more than seven days; intracranial bleeding; any other contraindication to limited heparinization) criteria for ECMO consideration in malaria and severe ARDS were used in the present case series.
Severe imported malaria is an important problem in the western world due to the increasing number of travellers returning from endemic countries who are non-adherent to malaria chemoprophylaxis . Most imported cases occur in non-immune patients in whom malaria can rapidly progress to severe disease, with mortality as high as 20 to 35%, even with adequate anti-malarial treatment . ARDS may develop in isolation or as part of a severe multisystem illness and often occurs within a few days of starting treatment when parasitaemia is falling . The pathogenesis of ARDS in malaria is not fully understood, though it may involve parasite sequestration in the pulmonary vasculature and up-regulation of pro-inflammatory cytokines, and may persist even after parasite clearance . However, parasite sequestration in the pulmonary vasculature seems to be relevant only for P. falciparum infection, given that in P. vivax malaria there is no substantial lung sequestration. Severe ARDS in patients with malaria has a poor prognosis, with mortality as high as 69 to 95% in observational ICU case series [22, 25]. Severe ARDS most commonly complicates P. falciparum infection and is rarely a complication of P. vivax or P. ovale infection. This could be related to differences in cyto-adhesion of infected erythrocytes [26–29]. However, it should be stressed that it is difficult to definitely establish malaria as the sole etiology for severe ARDS, fully excluding bacterial co-infection. Nevertheless, no documentation of bacterial co-infection was found despite extensive microbiology specimen collection and culture at ICU admission. This could support the assumption that malaria was the most probable cause for severe ARDS in the three cases presented in this report.
Risk factors associated with the development of ARDS in malaria include advanced age, lack of specific immunity, immunocompromised status, and pregnancy. A high parasitic burden is not necessary . In this case series, patients were either semi-immune or non-immune and parasitaemia was less than 4% in all patients.
There are only two prior cases reported separately on the use of ECMO for severe ARDS in patients with malaria, as well as one case on the use of extracorporeal carbon dioxide elimination [5, 12, 13]. In both cases of ECMO use, P. falciparum was identified as the causal organism and ECMO was instituted within seven days for refractory hypoxaemia, but only one patient survived [5, 12]. In the case of extracorporeal carbon elimination use, P. falciparum was also identified as the causal organism and extracorporeal carbon elimination was instituted on the 17th day, being discontinued after twelve days. The patient was weaned from mechanical ventilation and successfully discharged home . In the present case series, one of the two patients that initiated ECMO after more than seven days of IMV did not survive. Patients with ARDS who have been receiving IMV with excessively high plateau pressures or high fractions of inspired oxygen for more than seven days may be less likely to benefit from ECMO [31–35]. Earlier initiation of ECMO, for these or other reasons, has been associated with better outcomes in some, but not all, observational studies [33, 36–38].
Patients with severe forms of malaria are highly susceptible to bacterial infections and concomitant antibacterial therapy is recommended [2, 39]. All the three patients presented in this case series received adequate antimicrobial therapy, though one patient developed nosocomial infections and ultimately died of sepsis, despite appropriate antibacterial coverage.
ECMO-related complications in the present case series included cannula migration into a hepatic vein, which was identified by transesophageal echocardiogram and corrected at the bedside. Thrombus formation in the oxygenator was ultimately the cause for oxygenator exchange in one patient. However, the rate of thrombosis-associated oxygenator failure requiring device exchange is low, even at low levels of anticoagulation . Major bleeding complications, as occurred in one patient, are less frequent in the era of modern ECMO technology, given the ability to maintain circuit integrity at lower levels of anticoagulation, but they may still occur, especially in the setting of pre-existing thrombocytopaenia or coagulopathy.
In conclusion, severe ARDS can complicate P. falciparum, P. vivax, and P. ovale infection. In regions where the technology is available, ECMO referral should be considered for patients with malaria complicated by severe ARDS refractory to conventional treatment. Taking into account the limited experience with ECMO in severe malaria yet, its use should be performed in experienced ECMO centers. In fact, severe malaria can cause haemolysis, disseminated intravascular coagulation and low platelets, which might be exaggerated by the use of extracorporeal devices.
- Taylor WR, Hanson J, Turner GD, White NJ, Dondorp AM: Respiratory manifestations of malaria. Chest. 2012, 142: 492-505. 10.1378/chest.11-2655.View ArticlePubMedGoogle Scholar
- Santos LC, Abreu CF, Xerinda SM, Tavares M, Lucas R, Sarmento AC: Severe imported malaria in an intensive care unit: a review of 59 cases. Malar J. 2012, 11: 96-10.1186/1475-2875-11-96.PubMed CentralView ArticlePubMedGoogle Scholar
- Frickmann H, Schwarz NG, Holtherm HU, Maassen W, Vorderwulbecke F, Erkens K, Fischer M, Morwinsky T, Hagen RM: Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey. Infection. 2013, 41: 311-320. 10.1007/s15010-013-0411-5.View ArticlePubMedGoogle Scholar
- Bruneel F, Hocqueloux L, Alberti C, Wolff M, Chevret S, Bedos JP, Durand R, Le Bras J, Regnier B, Vachon F: The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med. 2003, 167: 684-689. 10.1164/rccm.200206-631OC.View ArticlePubMedGoogle Scholar
- Losert H, Schmid K, Wilfing A, Winkler S, Staudinger T, Kletzmayr J, Burgmann H: Experiences with severe P. falciparum malaria in the intensive care unit. Intensive Care Med. 2000, 26: 195-201. 10.1007/s001340050045.View ArticlePubMedGoogle Scholar
- De Nardo P, Oliva A, Giancola ML, Ghirga P, Mencarini P, Bibas M, Nicastri E, Antinori A, Corpolongo A: Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria. Infection. 2013, 41: 863-865. 10.1007/s15010-013-0451-x. Epub ahead of printView ArticlePubMedGoogle Scholar
- Brodie D, Bacchetta M: Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011, 365: 1905-1914. 10.1056/NEJMct1103720.View ArticlePubMedGoogle Scholar
- Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D: CESAR trial collaboration: efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009, 374: 1351-1363. 10.1016/S0140-6736(09)61069-2.View ArticlePubMedGoogle Scholar
- Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R, Jackson A, McGuinness S, Nair P, Pellegrino V, Pettilä V, Plunkett B, Pye R, Torzillo P, Webb S, Wilson M, Ziegenfuss M, Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators: Extracorporeal membrane oxygenation for 2009 Influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009, 302: 1888-1895.View ArticlePubMedGoogle Scholar
- Patroniti N, Zangrillo A, Pappalardo F, Peris A, Cianchi G, Braschi A, Iotti GA, Arcadipane A, Panarello G, Ranieri VM, Terragni P, Antonelli M, Gattinoni L, Oleari F, Pesenti A: The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med. 2011, 37: 1447-1457. 10.1007/s00134-011-2301-6.View ArticlePubMedGoogle Scholar
- Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, Sadique MZ, Sekhon JS, McAuley DF, Firmin RK, Harvey C, Cordingley JJ, Price S, Vuylsteke A, Jenkins DP, Noble DW, Bloomfield R, Walsh TS, Perkins GD, Menon D, Taylor BL, Rowan KM: Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA. 2011, 306: 1659-1668. 10.1001/jama.2011.1471.View ArticlePubMedGoogle Scholar
- Vandroux D, Leaute B, Hoarau N, Ursulet L, Djouhri S, Braunberger E, Gauzere BA: High frequency oscillation ventilation and extracorporeal membrane oxygenation during pernicious malaria. Med Mal Infect. 2011, 41: 209-212. 10.1016/j.medmal.2010.11.001.View ArticlePubMedGoogle Scholar
- Neurath M, Benzing A, Knolle P, Grundmann H, Dippold W, Meyer zum Buschenfelde KH: Acute respiratory failure in tropical malaria during pregnancy. Successful treatment using extracorporeal CO2 elimination. Dtsch Med Wochenschr. 1993, 118: 1060-1066. 10.1055/s-2008-1059426.View ArticlePubMedGoogle Scholar
- Javidfar J, Brodie D, Wang D, Ibrahimiye AN, Yang J, Zwischenberger JB, Sonett J, Bacchetta M: Use of bicaval dual-lumen catheter for adult venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2011, 91: 1763-1768. 10.1016/j.athoracsur.2011.03.002. discussion 1769View ArticlePubMedGoogle Scholar
- Javidfar J, Wang D, Zwischenberger JB, Costa J, Mongero L, Sonett J, Bacchetta M: Insertion of bicaval dual lumen extracorporeal membrane oxygenation catheter with image guidance. ASAIO J. 2011, 57: 203-205. 10.1097/MAT.0b013e3182155fee.View ArticlePubMedGoogle Scholar
- WHO: Guidelines for the treatment of malaria. 2010, Geneva: WHO,http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf,Google Scholar
- Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: the acute respiratory distress syndrome network. N Engl J Med. 2000, 342: 1301-1308.
- White NJ: Lumbar puncture in cerebral malaria. Lancet. 1991, 338: 640-641. 10.1016/0140-6736(91)90654-8.View ArticlePubMedGoogle Scholar
- Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, Esiri MM, Day NP, White NJ, Turner GD: Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis. 2012, 205: 663-671. 10.1093/infdis/jir812.PubMed CentralView ArticlePubMedGoogle Scholar
- Hanson JP, Lam SW, Mohanty S, Alam S, Pattnaik R, Mahanta KC, Hasan MU, Charunwatthana P, Mishra SK, Day NP, White NJ, Dondorp AM: Fluid resuscitation of adults with severe falciparum malaria: effects on acid–base status, renal function, and extravascular lung water. Crit Care Med. 2013, 41: 972-981. 10.1097/CCM.0b013e31827466d2.View ArticlePubMedGoogle Scholar
- Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, de Boisblanc B, Connors AF, Hite RD, Harabin AL: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006, 354: 2564-2575.View ArticlePubMedGoogle Scholar
- Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M: Severe Imported Malaria in Adults (SIMA) Study Group: severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One. 2010, 5: e13236-10.1371/journal.pone.0013236.PubMed CentralView ArticlePubMedGoogle Scholar
- Blumberg L, Lee RP, Lipman J, Beards S: Predictors of mortality in severe malaria: a two year experience in a non-endemic area. Anaesth Intensive Care. 1996, 24: 217-223.PubMedGoogle Scholar
- Maguire GP, Handojo T, Pain MC, Kenangalem E, Price RN, Tjitra E, Anstey NM: Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis. 2005, 192: 1966-1974. 10.1086/497697.PubMed CentralView ArticlePubMedGoogle Scholar
- Krishnan A, Karnad DR: Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med. 2003, 31: 2278-2284. 10.1097/01.CCM.0000079603.82822.69.View ArticlePubMedGoogle Scholar
- Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007, 77: 79-87.PubMed CentralPubMedGoogle Scholar
- Rojo-Marcos G, Cuadros-Gonzalez J, Mesa-Latorre JM, Culebras-Lopez AM, de Pablo-Sanchez R: Acute respiratory distress syndrome in a case of Plasmodium ovale malaria. Am J Trop Med Hyg. 2008, 79: 391-393.PubMedGoogle Scholar
- Lee EY, Maguire JH: Acute pulmonary edema complicating ovale malaria. Clin Infect Dis. 1999, 29: 697-698. 10.1086/598667.View ArticlePubMedGoogle Scholar
- Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire GP: Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis. 2007, 195: 589-596. 10.1086/510756.PubMed CentralView ArticlePubMedGoogle Scholar
- Jindal SK, Aggarwal AN, Gupta D: Adult respiratory distress syndrome in the tropics. Clin Chest Med. 2002, 23: 445-455. 10.1016/S0272-5231(01)00009-0.View ArticlePubMedGoogle Scholar
- Rouby JJ, Brochard L: Tidal recruitment and overinflation in acute respiratory distress syndrome: yin and yang. Am J Respir Crit Care Med. 2007, 175: 104-106. 10.1164/rccm.200610-1564ED.View ArticlePubMedGoogle Scholar
- Pugin J, Verghese G, Widmer MC, Matthay MA: The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med. 1999, 27: 304-312. 10.1097/00003246-199902000-00036.View ArticlePubMedGoogle Scholar
- Pranikoff T, Hirschl RB, Steimle CN, Anderson HL, Bartlett RH: Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997, 25: 28-32. 10.1097/00003246-199701000-00008.View ArticlePubMedGoogle Scholar
- Jackson RM: Pulmonary oxygen toxicity. Chest. 1985, 88: 900-905. 10.1378/chest.88.6.900.View ArticlePubMedGoogle Scholar
- Davis WB, Rennard SI, Bitterman PB, Crystal RG: Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med. 1983, 309: 878-883. 10.1056/NEJM198310133091502.View ArticlePubMedGoogle Scholar
- Beiderlinden M, Eikermann M, Boes T, Breitfeld C, Peters J: Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med. 2006, 32: 1627-1631. 10.1007/s00134-006-0262-y.View ArticlePubMedGoogle Scholar
- Mols G, Loop T, Geiger K, Farthmann E, Benzing A: Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg. 2000, 180: 144-154. 10.1016/S0002-9610(00)00432-3.View ArticlePubMedGoogle Scholar
- Lewandowski K, Rossaint R, Pappert D, Gerlach H, Slama KJ, Weidemann H, Frey DJ, Hoffmann O, Keske U, Falke KJ: High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med. 1997, 23: 819-835. 10.1007/s001340050418.View ArticlePubMedGoogle Scholar
- Abreu C, Santos L, Poinhos R, Sarmento A: Acute acalculous cholecystitis in malaria: a review of seven cases from an adult cohort. Infection. 2013, 41: 821-826. 10.1007/s15010-013-0452-9. Epub ahead of printView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.